Advertisement

MSCs in Reconstructive Surgery

  • Summer E. Hanson
  • Michael L. Bentz
Chapter
Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)

Abstract

Soft tissue defects remain a major challenge in modern medicine and ­represent a significant burden, affecting not only physical and mental health but also productivity, healthcare expenditure, and long-term morbidity. Even under optimal conditions, the healing process leads to some element of fibrosis or scarring. Cell-based treatments involve the transplantation of progenitor/stem cells to patients through local or systemic delivery and offer a novel approach to many diseases. Mesenchymal stromal cells (MSCs) are multipotent adult progenitor cells of great interest as cellular therapeutics because numerous studies have shown that MSCs, derived from bone marrow and other tissues, possess the ability to suppress activation and proliferation of immune cells, differentiate along multiple tissue lineages, and participate in the tissue healing process through a variety of other paracrine mechanisms. Better understanding of these potential interactions could translate to the development of clinically relevant, novel cell-based therapies for soft tissue reconstruction. The clinical role of tissue-derived MSCs, though not well understood, holds promise for many applications in novel cell therapies and regenerative medicine.

Keywords

Fibrin Glue Mesenchymal Stromal Cell Stromal Vascular Fraction Soft Tissue Augmentation Alveolar Cleft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Martin P (1997) Wound healing – aiming for perfect skin regeneration. Science 276(5309): 75–81PubMedCrossRefGoogle Scholar
  2. 2.
    Darby IA, Hewitson TD (2007) Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257:143–179PubMedCrossRefGoogle Scholar
  3. 3.
    American Society of Plastic Surgeons (2008) National plastic surgery statistics. Available at: www.plasticsurgery.org/media/statistics. Accessed 20 May 2009
  4. 4.
    Mustoe TA, O’Shaughnessy K, Kloeters O (2006) Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 117(7 Suppl):35S–41SPubMedGoogle Scholar
  5. 5.
    Panuncialman J, Falanga V (2007) The science of wound bed preparation. Clin Plast Surg 34(4):621–632PubMedCrossRefGoogle Scholar
  6. 6.
    Herdrich BJ, Lind RC, Liechty KW (2008) Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy 10(6):543–550PubMedCrossRefGoogle Scholar
  7. 7.
    Ehrenreich M, Ruszczak Z (2006) Update on tissue-engineered biological dressings. Tissue Eng 12(9):2407–2424PubMedCrossRefGoogle Scholar
  8. 8.
    Giordano A, Galderisi U, Marino IR (2007) From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211(1):27–35PubMedCrossRefGoogle Scholar
  9. 9.
    da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204–2213PubMedCrossRefGoogle Scholar
  10. 10.
    Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211–228PubMedCrossRefGoogle Scholar
  11. 11.
    Niemela SM, Miettinen S, Konttinen Y, Waris T, Kellomaki M, Ashammakhi NA et al (2007) Fat tissue: views on reconstruction and exploitation. J Craniofac Surg 18(2):325–335PubMedCrossRefGoogle Scholar
  12. 12.
    Coleman SR, Saboeiro AP (2007) Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 119(3):775–785; discussion 786–787PubMedCrossRefGoogle Scholar
  13. 13.
    Galie M, Pignatti M, Scambi I, Sbarbati A, Rigotti G (2008) Comparison of different centrifugation protocols for the best yield of adipose-derived stromal cells from lipoaspirates. Plast Reconstr Surg 122(6):233e–234ePubMedCrossRefGoogle Scholar
  14. 14.
    Piasecki JH, Gutowski KA, Moreno KM, Lahvis GL (2008) Purified viable fat suspended in matrigel improves volume longevity. Aesthet Surg J 28(1):24–32PubMedCrossRefGoogle Scholar
  15. 15.
    Matsumoto D, Sato K, Gonda K, Takaki Y, Shigeura T, Sato T et al (2006) Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 12(12):3375–3382PubMedCrossRefGoogle Scholar
  16. 16.
    Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E et al (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208(1):64–76PubMedCrossRefGoogle Scholar
  17. 17.
    Trivedi P, Hematti P (2008) Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 36(3):350–359PubMedGoogle Scholar
  18. 18.
    Hoogduijn MJ, Crop MJ, Peeters AM, Van Osch GJ, Balk AH, Ijzermans JN et al (2007) Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16(4):597–604PubMedCrossRefGoogle Scholar
  19. 19.
    Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C et al (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129(1):118–129PubMedCrossRefGoogle Scholar
  20. 20.
    Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213(2):341–347PubMedCrossRefGoogle Scholar
  21. 21.
    Uccelli A, Pistoia V, Moretta L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28(5):219–226PubMedCrossRefGoogle Scholar
  22. 22.
    Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem Cells 25(11):2896–2902PubMedCrossRefGoogle Scholar
  23. 23.
    Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11):2739–2749PubMedCrossRefGoogle Scholar
  24. 24.
    Dazzi F, Horwood NJ (2007) Potential of mesenchymal stem cell therapy. Curr Opin Oncol 19(6):650–655PubMedCrossRefGoogle Scholar
  25. 25.
    Hematti P (2008) Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22(4):262–273CrossRefGoogle Scholar
  26. 26.
    Le Blanc K, Ringden O (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262(5):509–525PubMedCrossRefGoogle Scholar
  27. 27.
    Rasmusson I, Uhlin M, Le Blanc K, Levitsky V (2007) Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 82(4):887–893PubMedCrossRefGoogle Scholar
  28. 28.
    Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10):3499–3506PubMedCrossRefGoogle Scholar
  29. 29.
    Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37(12):1445–1453PubMedCrossRefGoogle Scholar
  30. 30.
    Schaffler A, Buchler C (2007) Concise review: adipose tissue-derived stromal cells – basic and clinical implications for novel cell-based therapies. Stem Cells 25(4):818–827PubMedCrossRefGoogle Scholar
  31. 31.
    Yoshimura K, Sato K, Aoi N, Kurita M, Inoue K, Suga H et al (2008) Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 34(9):1178–1185PubMedCrossRefGoogle Scholar
  32. 32.
    Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y et al (2008) Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 121(3):860–877PubMedCrossRefGoogle Scholar
  33. 33.
    Hanson SE, Bentz ML, Hematti P (2010) Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 125(2):510–516PubMedCrossRefGoogle Scholar
  34. 34.
    Hanson SE, Gutowski KA, Hematti P (2010) Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthet Surg J 30(6):838–842PubMedCrossRefGoogle Scholar
  35. 35.
    Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA et al (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372(9655):2023–2030PubMedCrossRefGoogle Scholar
  36. 36.
    Gutowski KA, ASPS Fat Graft Task Force (2009) Current applications and safety of autologous fat grafts: a report of the ASPS fat graft task force. Plast Reconstr Surg 124(1):272–280PubMedCrossRefGoogle Scholar
  37. 37.
    Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K (2008) Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 32(1):48–55; discussion 56–57PubMedCrossRefGoogle Scholar
  38. 38.
    Park BS, Jang KA, Sung JH, Park JS, Kwon YH, Kim KJ et al (2008) Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 34(10):1323–1326PubMedCrossRefGoogle Scholar
  39. 39.
    Badiavas EV, Falanga V (2003) Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 139(4):510–516PubMedCrossRefGoogle Scholar
  40. 40.
    Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N et al (2007) Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13(6):1299–1312PubMedCrossRefGoogle Scholar
  41. 41.
    Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC (2009) Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 12(5):359–366PubMedCrossRefGoogle Scholar
  42. 42.
    Lataillade JJ, Doucet C, Bey E, Carsin H, Huet C, Clairand I et al (2007) New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2(5):785–794PubMedCrossRefGoogle Scholar
  43. 43.
    Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F et al (2010) Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 18(1):50–58PubMedCrossRefGoogle Scholar
  44. 44.
    Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48(7):1416–1423PubMedCrossRefGoogle Scholar
  45. 45.
    Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52(1):79–86PubMedCrossRefGoogle Scholar
  46. 46.
    Rigotti G, Marchi A, Galie M, Baroni G, Benati D, Krampera M et al (2007) Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 119(5):1409–1422; discussion 1423–1424PubMedCrossRefGoogle Scholar
  47. 47.
    Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF (2007) Impaired wound healing. Clin Dermatol 25(1):19–25PubMedCrossRefGoogle Scholar
  48. 48.
    Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367(9518):1241–1246PubMedCrossRefGoogle Scholar
  49. 49.
    Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G (2007) Bioengineered skin substitutes for the management of burns: a systematic review. Burns 33(8):946–957PubMedCrossRefGoogle Scholar
  50. 50.
    Macchiarini P, Walles T, Biancosino C, Mertsching H (2004) First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 128(4):638–641PubMedCrossRefGoogle Scholar
  51. 51.
    Caplan AI (2009) New era of cell-based orthopedic therapies. Tissue Eng Part B Rev 15(2): 195–200PubMedCrossRefGoogle Scholar
  52. 52.
    Rickert D, Sauerbier S, Nagursky H, Menne D, Vissink A, Raghoebar GM (2010) Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial. Clin Oral Implants Res 22(3): 251–258PubMedCrossRefGoogle Scholar
  53. 53.
    Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N (2008) Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(2):203–209PubMedCrossRefGoogle Scholar
  54. 54.
    Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA (2008) Cell based bone tissue engineering in jaw defects. Biomaterials 29(21):3053–3061PubMedCrossRefGoogle Scholar
  55. 55.
    Witte MB, Barbul A (1997) General principles of wound healing. Surg Clin North Am 77(3):509–528PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Plastic and Reconstructive SurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations